GlaxoSmithKline
GSK
$30.41
Share price
-0.98%
Change (1 day)
-20.43%
Change (1 year)
Categories
Earnings for GlaxoSmithKline (GSK)
Earnings in 2022 (TTM): $7.80 B
According to GlaxoSmithKline's latest financial reports the company's current earnings (TTM) are $7.80 B. In 2021 the company made an earning of $7.42 B a decrease over its 2020 earnings that were of $8.79 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for GlaxoSmithKline from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $7.80 B | 5.1% |
| 2021 | $7.42 B | -15.57% |
| 2020 | $8.79 B | 10.81% |
| 2019 | $7.93 B | 25.28% |
| 2018 | $6.33 B | 37.91% |
| 2017 | $4.59 B | 80.02% |
| 2016 | $2.55 B | -83.68% |
| 2015 | $15.63 B | 219.06% |
| 2014 | $4.89 B | -53.64% |
| 2013 | $10.56 B | -1.3% |
| 2012 | $10.70 B | -12.13% |
| 2011 | $12.18 B | 149.01% |
| 2010 | $4.89 B | -60.81% |
| 2009 | $12.48 B | 2.43% |
| 2008 | $12.19 B | -19.37% |
| 2007 | $15.12 B | 4.65% |
| 2006 | $14.44 B | 19.85% |
| 2005 | $12.05 B | 5.67% |
| 2004 | $11.40 B | 4.26% |
| 2003 | $10.94 B | 15.63% |
| 2002 | $9.46 B | -9.52% |
| 2001 | $10.45 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $24.89 B | 219.11% | 🇨🇭 Switzerland |
 Pfizer PFE | $33.77 B | 332.95% | 🇺🇸 USA |
 Sanofi SNY | $9.45 B | 21.23% | 🇫🇷 France |
 Merck MRK | $19.41 B | 148.85% | 🇺🇸 USA |
 Astrazeneca AZN | -$0.55 B | -106.96% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$1.13 B | -114.46% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.24 B | -96.91% | 🇺🇸 USA |